(Q49917841)

English

Early safety and efficacy of the combination of bedaquiline and delamanid for the treatment of patients with drug-resistant tuberculosis in Armenia, India, and South Africa: a retrospective cohort study.

scientific article published on 13 February 2018

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29452942%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Early safety and efficacy of the combination of bedaquiline and delamanid for the treatment of patients with drug-resistant tuberculosis in Armenia, India, and South Africa: a retrospective cohort study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29452942%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Chinmay Laxmeshwar

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29452942%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Jennifer Hughes

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29452942%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Petros Isaakidis

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29452942%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Sylvie Jonckheere

6

object named as

Sylvie Jonckheere

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29452942%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

author name string

Gabriella Ferlazzo

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29452942%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Erika Mohr

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29452942%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Catherine Hewison

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29452942%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Naira Khachatryan

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29452942%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Virginia De Avezedo

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29452942%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Lusine Egazaryan

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29452942%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Amir Shroufi

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29452942%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Stobdan Kalon

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29452942%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Helen Cox

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29452942%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Jennifer Furin

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29452942%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

publication date

13 February 2018

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29452942%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Lancet Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29452942%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29452942%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29452942%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

536-544

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29452942%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930100-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term outcomes of patients with extensively drug-resistant tuberculosis in South Africa: a cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930100-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Delamanid for multidrug-resistant pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930100-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Multidrug-resistant tuberculosis and culture conversion with bedaquiline.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930100-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930100-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Bedaquiline and multidrug-resistant tuberculosis: a systematic and critical analysis of the evidence.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930100-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Multidrug-resistant tuberculosis and beyond: an updated analysis of the current evidence on bedaquiline

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930100-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiac safety of bedaquiline: a systematic and critical analysis of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930100-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930100-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Bedaquiline plus delamanid for XDR tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930100-2

7 January 2021

based on heuristic

inferred from DOI database lookup

First case of extensively drug-resistant tuberculosis treated with both delamanid and bedaquiline

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930100-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930100-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The need to accelerate access to new drugs for multidrug-resistant tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930100-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930100-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug-resistant tuberculosis clinical trials: proposed core research definitions in adults.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930100-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Compassionate use of bedaquiline for the treatment of multidrug-resistant and extensively drug-resistant tuberculosis: interim analysis of a French cohort

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930100-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment outcomes for extensively drug-resistant tuberculosis and HIV co-infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930100-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Linezolid for the treatment of complicated drug-resistant tuberculosis: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930100-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Transmission of Extensively Drug-Resistant Tuberculosis in South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930100-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical impact and cost of monitoring for asymptomatic laboratory abnormalities among patients receiving antiretroviral therapy in a resource-poor setting

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2818%2930100-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1473-3099(18)30100-2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29452942%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29452942%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q49917841&oldid=2135499202"